Lexaria Bioscience dismisses CFO Gregory Downey; CEO assumes principal financial officer role

Lexaria Bioscience Corp.

Gregory Downey dismissed as CFO effective June 6, 2023; company actively seeking replacement.
Interim CFO services provided by Mike Shankman of NOW CFO; Shankman is CPA with MBA, healthcare experience.
CEO Chris Bunka assumes role of principal financial officer; no additional compensation for Bunka.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Chris Bunka

Principal Financial Officer

LEXX · Lexaria Bioscience Corp.

Filed: June 12, 2023, 7:59 PM ET

The Company’s Chief Executive Officer, Chris Bunka, will assume the role of principal financial officer at this time.

Departed

Gregory Downey

Chief Financial Officer

LEXX · Lexaria Bioscience Corp.

Effective: 2023-06-06
Filed: June 12, 2023, 7:59 PM ET

Effective June 6, 2023, Mr. Gregory Downey was dismissed as the Company’s Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chris Bunka changed role as Principal Financial Officer at Lexaria Bioscience Corp..

Action: assumed
Role: Principal Financial Officer

Exact text from the filing

The Company’s Chief Executive Officer, Chris Bunka, will assume the role of principal financial officer at this time.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gregory Downey departed as Chief Financial Officer at Lexaria Bioscience Corp..

Action: dismissed
Role: Chief Financial Officer

Exact text from the filing

Effective June 6, 2023, Mr. Gregory Downey was dismissed as the Company’s Chief Financial Officer.

View on SEC.gov

Lexaria Bioscience Corp. filing history →

Source: SEC EDGAR

accession 0001640334-23-001035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.